MilliporeSigma Celebrates Groundbreaking of First Lateral Flow Membrane Production Facility
MilliporeSigma recently celebrated the groundbreaking of its first lateral flow membrane production facility in the United States.
Located in Sheboygan, Wisconsin, the new production facility — a project collaboration with Flad Architects and J.H. Findorff & Son, Inc. (Findorff) — supports the manufacturing of MilliporeSigma’s Hi-Flow™ Plus lateral flow membranes used in a variety of diagnostic testing applications, including rapid test kits for COVID-19.
Pictured above (left to right): Jim Yehle (President & CEO, Findorff), Bryan Haddon (Process Engineer, AEI), Jason Mattila (Principal, Findorff), Graham McLeod (Instrumentation & Controls Engineer, AEI), Brad Olson (Project Manager, Findorff), Chad Eschler (Business Development, Findorff), Bob Hougard (Director of Science & Technology, Findorff).
Jean Charles-Wirth, Head of Science & Lab Solutions, Life Science business of Merck KGaA, Germany (left), and Dr. Iva Morse, Vice President of BioProcessing Commercial, Americas, MilliporeSigma, and the United States Country Speaker for Merck KGaA, Darmstadt Germany (right), chat with Wisconsin Governor Tony Evers (middle) at the experiential lateral flow membrane product display at the MilliporeSigma groundbreaking ceremony held on July 18, 2022. (Photo credit: Jeffrey Phelps/AP Images for MilliporeSigma)
“From COVID-19 rapid testing to cancer therapies...this new facility will provide a major step forward in expanding domestic diagnostic testing...ensuring our state and country are ready to tackle any public health crisis that comes our way now and into the future.”
In addition to providing greater customer flexibility and supply chain security, the facility will expand MilliporeSigma’s regional network, enhance access to raw materials, and increase local production capacity to support surge market demands.
AEI is providing process, mechanical, electrical, and piping/plumbing engineering design for the state-of-the-art new production facility.
Left to right: City of Sheboygan Mayor Ryan Sorenson, Dr. Iva Morse, Vice President of BioProcessing Commercial, Americas, MilliporeSigma, and the U.S. Speaker for Merck KGaA, Darmstadt Germany, Wisconsin Governor Tony Evers, Jean Charles-Wirth, Head of Science & Lab Solutions, Life Science business of Merck KGaA, Germany, Missy Hughes, Secretary and CEO, Wisconsin Economic Development Corporation. (Photo credit: Jeffrey Phelps/AP Images for MilliporeSigma)